Related Experiment Video
Updated: Jul 14, 2025
08:14
MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
15.7K
Lung Cancer Screening: The European Perspective
Piergiorgio Muriana1, Francesca Rossetti1, Pierluigi Novellis1
1Department of Thoracic Surgery, San Raffaele Scientific Institute, Via Olgettina 60, Milan 20132, Italy.
Thoracic Surgery Clinics
|October 8, 2023
Summary
European studies advanced lung cancer screening knowledge. Low-dose computed tomography (LDCT) is key for high-risk smokers over 50, improving risk modeling and outcomes.
Area of Science:
- Oncology
- Radiology
- Public Health
Background:
- Lung cancer screening research has advanced significantly in Europe.
- Studies focused on low-dose computed tomography (LDCT) for early detection.
Purpose of the Study:
- To summarize European contributions to lung cancer screening knowledge.
- To highlight advancements in screening high-risk individuals.
Main Methods:
- Review of randomized and observational studies on LDCT screening.
- Analysis of data on risk modeling, diagnostic protocols, and outcomes.
Main Results:
- Significant progress in risk modeling and defining screening intervals.
- Improvements in diagnostic protocols, including volumetry and overdiagnosis estimation.
- Better understanding of oncological outcomes and radiation risks.
Conclusions:
- European studies have enhanced understanding of LDCT lung cancer screening.
- Key areas of advancement include risk assessment, protocol optimization, and patient communication.
